Clinical-grade whole genome sequencing of colorectal cancer and 3’ transcriptome analysis demonstrate targetable alterations in the majority of patients
Agata Stodolna, Miao He, Mahesh Vasipalli, Zoya Kingsbury, Jennifer Becq, Joanne D Stockton, Mark P Dilworth, Jonathan James, Toju Sillo, Daniel Blakeway, Stephen T Ward, Tariq Ismail, Mark T. Ross, View ORCID ProfileAndrew D. Beggs
doi: https://doi.org/10.1101/2020.04.26.20080887
Agata Stodolna
1Institute of Cancer and Genomic Medicine, College of Medical and Dental Sciences, University of Birmingham
Miao He
2Illumina Cambridge, Granta Park, Cambridge
Mahesh Vasipalli
2Illumina Cambridge, Granta Park, Cambridge
Zoya Kingsbury
2Illumina Cambridge, Granta Park, Cambridge
Jennifer Becq
2Illumina Cambridge, Granta Park, Cambridge
Joanne D Stockton
1Institute of Cancer and Genomic Medicine, College of Medical and Dental Sciences, University of Birmingham
Mark P Dilworth
1Institute of Cancer and Genomic Medicine, College of Medical and Dental Sciences, University of Birmingham
Jonathan James
1Institute of Cancer and Genomic Medicine, College of Medical and Dental Sciences, University of Birmingham
Toju Sillo
1Institute of Cancer and Genomic Medicine, College of Medical and Dental Sciences, University of Birmingham
Daniel Blakeway
1Institute of Cancer and Genomic Medicine, College of Medical and Dental Sciences, University of Birmingham
Stephen T Ward
3University Hospitals Birmingham NHS Foundation Trust
Tariq Ismail
3University Hospitals Birmingham NHS Foundation Trust
Mark T. Ross
2Illumina Cambridge, Granta Park, Cambridge
Andrew D. Beggs
1Institute of Cancer and Genomic Medicine, College of Medical and Dental Sciences, University of Birmingham
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Data will be made available on acceptance of the manuscript on EGA
Posted May 01, 2020.
Clinical-grade whole genome sequencing of colorectal cancer and 3’ transcriptome analysis demonstrate targetable alterations in the majority of patients
Agata Stodolna, Miao He, Mahesh Vasipalli, Zoya Kingsbury, Jennifer Becq, Joanne D Stockton, Mark P Dilworth, Jonathan James, Toju Sillo, Daniel Blakeway, Stephen T Ward, Tariq Ismail, Mark T. Ross, Andrew D. Beggs
medRxiv 2020.04.26.20080887; doi: https://doi.org/10.1101/2020.04.26.20080887
Clinical-grade whole genome sequencing of colorectal cancer and 3’ transcriptome analysis demonstrate targetable alterations in the majority of patients
Agata Stodolna, Miao He, Mahesh Vasipalli, Zoya Kingsbury, Jennifer Becq, Joanne D Stockton, Mark P Dilworth, Jonathan James, Toju Sillo, Daniel Blakeway, Stephen T Ward, Tariq Ismail, Mark T. Ross, Andrew D. Beggs
medRxiv 2020.04.26.20080887; doi: https://doi.org/10.1101/2020.04.26.20080887
Subject Area
Subject Areas
- Addiction Medicine (347)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2642)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12213)
- Forensic Medicine (10)
- Gastroenterology (758)
- Genetic and Genomic Medicine (4089)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2650)
- Health Policy (1004)
- Hematology (362)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3866)
- Nursing (209)
- Nutrition (577)
- Oncology (2025)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (450)
- Public and Global Health (6518)
- Radiology and Imaging (1399)
- Respiratory Medicine (871)
- Rheumatology (406)
- Sports Medicine (342)
- Surgery (446)
- Toxicology (53)
- Transplantation (185)
- Urology (165)